Health care-associated infections declined in 2010

Despite successes, more work is needed to ensure safe care and eliminate health care-associated infections

 

Atlanta, GA, USA (October 19, 2011) – Four common infections seen in health care facilities declined in 2010, according to the Centers for Disease Control and Prevention.  In a policy summit at the National Journal in Washington D.C., CDC staff detailed the reductions that are occurring in infection rates in U.S. hospitals. “Hospitals continue to make impressive progress in driving down certain infections in intensive care units through implementation of CDC prevention strategies,” said CDC Director Thomas R. Frieden, M.D., M.P.H. “Hospitals and state health departments need to translate this progress to other areas of health care delivery and health care infections, such as dialysis and ambulatory surgery centers, and diarrheal infections such as Clostridium difficile.”

The data were submitted by hospitals to the National Healthcare Safety Network, CDC’s health care infection monitoring system.  The number of infections reported was compared to a national baseline.  All of the infections reported have national prevention target goals as defined in the U.S. Department of Health and Human Services’ Action Plan to Prevent Healthcare-Associated Infections.

 

CDC reported for 2010:

 

  • A 33 percent reduction in central line-associated bloodstream infections: a 35 percent reduction among critical care patients and a 26 percent reduction among non-critical care patients. A central line is a tube that is placed in a large vein of a patient’s neck or chest to give important medical treatment. When not put in correctly or kept clean, central lines can become a freeway for germs to enter the body and cause serious bloodstream infections.
  • A 7 percent reduction in catheter-associated urinary tract infections throughout hospitals
  • A 10 percent reduction in surgical site infections
  • An 18 percent reduction in the number of people developing health care-associated invasive methicillin resistant Staphylococcus aureus (MRSA) infections

 

In addition, CDC saw improvement in health care provider adherence to proven infection prevention measures, such as appropriate techniques for inserting central line catheters into patients (over 94 percent adherence).  Two additional infections are currently being tracked, Clostridium difficile infections and MRSA bloodstream infections, and data on these infections will be available next year. 

 

“These successes reflect investments not only in hospital practices, but in our national and state public health capacity,” said Denise Cardo, M.D., director of CDC’s Division of Healthcare Quality Promotion.  “Preventing infections in health care saves lives and reduces health care costs.”

 

CDC has a unique role in the prevention of healthcare-associated infections in the United States. 

 

  • CDC responds to disease outbreaks in health care settings, providing health care facilities and states with resources to prevent future incidents.
  • CDC laboratories provide gold-standard testing of existing and emerging infectious threats to health care.
  • CDC guidelines are used by clinicians to prevent health care-associated infections; they form the basis for useful checklists to improve care.
  • CDC tracks health care-associated infections through the National Healthcare Safety Network, providing real-time data at the local, state, and national levels.

 

CDC supports the Partnership for Patients initiative, focused on protecting patients in America’s health care facilities through the prevention of health care-acquired conditions.  Federal initiatives, including Partnership for Patients and the HHS Action Plan to Prevent Healthcare-Associated Infections, aim to accelerate the prevention progress happening throughout the country.

 

The National Journal policy summit, titled “Spreading Success: Encouraging Best Practices in Infection Prevention” was held on Oct. 19 in Washington, D.C., and hosted by the Association for Professionals in Infection Control and Epidemiology (www.apic.org)

 

For a detailed summary of the infection data reported by CDC, please see the HHS website: http://www.hhs.gov/ash/initiatives/hai/nationaltargets/index.html

 


 

Centers for Disease Control and Prevention, 19.10.2011 (tB).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle
Deutscher Schmerz- und Palliativtag 2020 – ONLINE
Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…
DBfK: Besondere Rolle für Pflegeexpert/innen Schmerz – nicht nur in…

DIABETES

“Körperstolz”: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Finanzierung der ambulanten Krebsberatung weiterhin nicht gesichert
Lungenkrebsscreening mittels Low-Dose-CT

MULTIPLE SKLEROSE

Geschützt: Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…